Not recruiting yet
5G Remote Robotic Surgery for Hepatic Echinococcosis in High-Altitude Region
NCT07551063 · West China Hospital · Updated 24 April 2026
- What is being tested
- 5G-based Telerobotic Hepatectomy
- For
- Hepatic Echinococcosis
- Kind of study
- Tests a treatment or device on volunteers. Early phase 1.
- Who can join
- Ages 18 years to 80 years. About 10 people. The full rules are on the registry page.
- Where
- China
- When
- Starts or started 1 May 2026, ends 1 Oct 2026. Registered 24 April 2026.
- Results
- None posted yet.
In the researchers' words
Hepatic echinococcosis (HE) is a serious endemic parasitic disease in high-altitude regions like Xizang. Radical hepatectomy is the primary curative treatment, but expert resources are often concentrated in large medical centers. This prospective, single-arm study aims to evaluate the feasibility and safety of performing remote robotic hepatectomy using the Chinese Toumai™ robotic system over a 5G network. Ten patients in West China Hospital Tibet Hospital, Sichuan University (Lhasa, 3650m altitude) will undergo surgery performed by expert surgeons at West China Hospital (Chengdu). The primary focus is the surgical success rate and perioperative safety.
Sites
- West China Hospital, Sichuan UniversityChengdu, Sichuan / 四川, China
